APPLIED GENETIC TECHNOLOGIES (AGTC) Stock Analyst Earnings Estimates
NASDAQ:AGTC - Nasdaq - US03820J1007 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.45M -94.12% | 500K -79.59% | 325K -35.00% | 51K -84.31% | 77.265K 51.50% | 11.434M 14,698.42% | 631.27M 5,420.99% | 18.09B 2,765.65% | |
| EBITDA YoY % growth | -45.13M -1,365.26% | -55.355M -22.66% | -64.338M -16.23% | -70.278M -9.23% | -74.868M -6.53% | -72.93M 2.59% | -70.091M 3.89% | -68.709M 1.97% | |
| EBIT YoY % growth | -46.47M -968.28% | -56.815M -22.26% | -65.85M -15.90% | -75.54M -14.72% | -80.655M -6.77% | -81.177M -0.65% | -76.633M 5.60% | -73.791M 3.71% | |
| Operating Margin | -1,896.73% | -11,363.00% | -20,261.54% | -148,117.60% | -104,387.79% | -709.96% | -12.14% | -0.41% | |
| EPS YoY % growth | -2.17 -1,872.73% | -1.88 13.36% | -1.54 18.09% | -0.94 38.73% | -0.73 22.70% | -1.04 -42.31% | -0.92 11.57% | -0.83 9.80% |
All data in USD
| Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.19 58.07% | -0.11 66.00% | -0.12 66.00% | -0.12 56.29% | -0.12 35.14% | -0.41 -263.64% | -0.45 -266.67% | -0.46 -275.00% | -0.49 -300.00% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBITDA Q2Q % growth | -17.85M -1.84% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -21.581M -18.07% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | -0.28 30.00% | -0.20 | -0.08 | -37.25% |
| Q4 2022 Q2Q % growth | -0.36 -28.57% | -0.31 | -0.05 | -14.78% |
| Q3 2022 Q2Q % growth | -0.33 17.50% | -0.29 | -0.04 | -15.55% |
| Q2 2022 Q2Q % growth | -0.45 25.00% | -0.34 | -0.11 | -30.86% |
| Q1 2022 Q2Q % growth | -0.40 33.33% | -0.44 | 0.04 | 8.19% |
| Q4 2021 Q2Q % growth | -0.28 50.00% | -0.39 | 0.11 | 28.23% |
| Q3 2021 Q2Q % growth | -0.40 20.00% | -0.36 | -0.04 | -12.04% |
| Q2 2021 Q2Q % growth | -0.60 -27.66% | -0.41 | -0.19 | -47.06% |
| Q1 2021 Q2Q % growth | -0.60 6.25% | -0.42 | -0.18 | -42.60% |
| Q4 2020 Q2Q % growth | -0.56 3.45% | -0.60 | 0.04 | 6.68% |
| Q3 2020 Q2Q % growth | -0.50 -179.37% | -0.54 | 0.04 | 7.80% |
| Q2 2020 Q2Q % growth | -0.47 -104.35% | -0.49 | 0.02 | 4.29% |
| Q1 2020 Q2Q % growth | -0.64 -1,014.29% | -0.56 | -0.08 | -14.08% |
| Q4 2019 Q2Q % growth | -0.58 | -0.62 | 0.04 | 6.27% |
| Q3 2019 Q2Q % growth | 0.63 | -0.61 | 1.24 | 203.29% |
| Q2 2019 Q2Q % growth | -0.23 | -0.55 | 0.32 | 58.24% |
| Q1 2019 Q2Q % growth | 0.07 | -0.59 | 0.66 | 111.78% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | 325K -35.00% | 325K | % | |
| Q3 2021 Q2Q % growth | 84.997K | -84.997K | -100.00% | |
| Q2 2021 Q2Q % growth | -100.00% | % | ||
| Q4 2020 Q2Q % growth | -100.00% | % | ||
| Q3 2020 Q2Q % growth | -100.00% | 102K | -102K | -100.00% |
| Q2 2020 Q2Q % growth | 2.45M -58.68% | 2.45M | % | |
| Q1 2020 Q2Q % growth | -100.00% | 40.8K | -40.8K | -100.00% |
| Q3 2019 Q2Q % growth | 21.32M | 40.8K | 21.279M | 52,154.90% |
| Q2 2019 Q2Q % growth | 5.93M | 181.05K | 5.749M | 3,175.34% |
| Q1 2019 Q2Q % growth | 14.03M | 2.708M | 11.322M | 418.09% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -8.82% | N/A | 0% | N/A |
| Revenue | N/A | N/A | 0% | N/A |